Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Galera Therapeutics(GRTX) the EBIT is -1.655 M (+15.69%);the EPS is -1.47 (-0.83%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B15.69%
----
----
EPS
-1.47410.83%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf